{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:00:38Z","timestamp":1791165638456,"version":"4.1.0"},"reference-count":128,"publisher":"Hindawi Limited","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1177,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Mutat."],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1002\/humu.22124","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T17:38:43Z","timestamp":1337794723000},"page":"1398-1407","source":"Crossref","is-referenced-by-count":55,"title":["Gaucher disease paradigm: From ERAD to comorbidity"],"prefix":"10.1155","volume":"33","author":[{"given":"Inna","family":"Bendikov-Bar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2012,6,11]]},"reference":[{"key":"10.1002\/humu.22124-BIB1|cit1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bcmd.2005.05.007","article-title":"Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations","volume":"35","author":"Alfonso","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"10.1002\/humu.22124-BIB2|cit2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cca.2010.11.013","article-title":"Characterization of the c.(-203)A>G variant in the glucocerebrosidase gene and its association with phenotype in Gaucher disease","volume":"412","author":"Alfonso","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1002\/humu.22124-BIB3|cit3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bcmd.2009.02.008","article-title":"Glucocerebrosidase gene mutations in black South Africans with Gaucher disease","volume":"43","author":"Arndt","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"10.1002\/humu.22124-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/hmg\/ddn124","article-title":"A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome","volume":"17","author":"Balreira","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.22124-BIB5|cit5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00279398","article-title":"Assignment of the gene coding for human \u00df-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies","volume":"64","author":"Barneveld","year":"1983","journal-title":"Hum Genet"},{"key":"10.1002\/humu.22124-BIB6|cit6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2010.10.012","article-title":"Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant","volume":"46","author":"Bendikov-Bar","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1002\/humu.22124-BIB7|cit7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/13543776.2011.569162","article-title":"Pharmacological chaperone therapy for Gaucher disease: a patent review","volume":"21","author":"Benito","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"10.1002\/humu.22124-BIB8|cit8","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1016\/S0021-9258(18)82412-7","article-title":"Human acid beta-glucosidase. N-glycosylation site occupancy and the effect of glycosylation on enzymatic activity","volume":"268","author":"Berg-Fussman","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.22124-BIB9|cit9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0065-2660(08)60202-3","article-title":"Gaucher disease","volume":"32","author":"Beutler","year":"1995","journal-title":"Adv Genet"},{"key":"10.1002\/humu.22124-BIB10|cit10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2141.1993.tb03185.x","article-title":"Gaucher disease mutations in non-Jewish patients","volume":"85","author":"Beutler","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1002\/humu.22124-BIB11|cit11","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1073\/pnas.88.23.10544","article-title":"Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state","volume":"88","author":"Beutler","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.22124-BIB12|cit12","volume-title":"Gaucher Disease","author":"Beutler","year":"2001"},{"key":"10.1002\/humu.22124-BIB13|cit13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/hmg\/ddp523","article-title":"Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase","volume":"19","author":"Blanz","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.22124-BIB14|cit14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.54.1.261","article-title":"Gaucher disease with oculomotor apraxia and cardiovascular calcification (Gaucher type IIIC)","volume":"54","author":"Bohlega","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/humu.22124-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/archneur.1993.00540110088009","article-title":"The role of neurogenetics in Gaucher disease","volume":"50","author":"Brady","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1002\/humu.22124-BIB16|cit16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of Glucocerebrosides. Ii. Evidence of an enzymatic deficiency in Gaucher's disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/humu.22124-BIB17|cit17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.semcdb.2007.09.001","article-title":"The activities and function of molecular chaperones in the endoplasmic reticulum","volume":"18","author":"Buck","year":"2007","journal-title":"Semin Cell Dev Biol"},{"key":"10.1002\/humu.22124-BIB18|cit18","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J"},{"key":"10.1002\/humu.22124-BIB19|cit19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/bchm3.1986.367.2.879","article-title":"Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant","volume":"367","author":"Christomanou","year":"1986","journal-title":"Biol Chem Hoppe Seyler"},{"key":"10.1002\/humu.22124-BIB20|cit20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/BF01716064","article-title":"Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder","volume":"67","author":"Christomanou","year":"1989","journal-title":"Klin Wochenschr"},{"key":"10.1002\/humu.22124-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/humu.22124-BIB22|cit22","first-page":"299","article-title":"Gaucher disease: clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics"},{"key":"10.1002\/humu.22124-BIB23|cit23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to gaucher disease, Parkinson disease, and lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1002\/humu.22124-BIB24|cit24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1002\/humu.22124-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1021\/jm101204u","article-title":"New glucocerebrosidase inhibitors by exploration of chemical diversity of N-substituted aminocyclitols using click chemistry and in situ screening","volume":"54","author":"Diaz","year":"2011","journal-title":"J Med Chem"},{"key":"10.1002\/humu.22124-BIB26|cit26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00439-005-1288-x","article-title":"A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity","volume":"117","author":"Diaz-Font","year":"2005","journal-title":"Hum Genet"},{"key":"10.1002\/humu.22124-BIB27|cit27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-5793(99)00274-4","article-title":"Accumulation of protein-bound epidermal glucosylceramides in beta-glucocerebrosidase deficient type 2 Gaucher mice","volume":"447","author":"Doering","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1002\/humu.22124-BIB28|cit28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12519-011-0309-1","article-title":"Glucosidase acid beta gene mutations in Egyptian children with Gaucher disease and relation to disease phenotypes","volume":"7","author":"El-Morsy","year":"2011","journal-title":"World J Pediatr"},{"key":"10.1002\/humu.22124-BIB29|cit29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmg.2008.02.004","article-title":"Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene","volume":"51","author":"Emre","year":"2008","journal-title":"Eur J Med Genet"},{"key":"10.1002\/humu.22124-BIB30|cit30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-1119(90)90264-R","article-title":"Prevalent and rare mutations among Gaucher patients","volume":"96","author":"Eyal","year":"1990","journal-title":"Gene"},{"key":"10.1002\/humu.22124-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/hmg\/ddp061","article-title":"No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease","volume":"18","author":"Farfel-Becker","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.22124-BIB32|cit32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/bchm3.1988.369.1.317","article-title":"The precursor of sulfatide activator protein is processed to three different proteins","volume":"369","author":"Furst","year":"1988","journal-title":"Biol Chem Hoppe Seyler"},{"key":"10.1002\/humu.22124-BIB33|cit33","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1093\/hmg\/ddq419","article-title":"Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1\/parkin-dependent manner upon induction of mitophagy","volume":"19","author":"Gegg","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.22124-BIB34|cit34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/auto.7.2.14332","article-title":"PINK1-parkin-dependent mitophagy involves ubiquitination of mitofusins 1 and 2: implications for Parkinson disease pathogenesis","volume":"7","author":"Gegg","year":"2011","journal-title":"Autophagy"},{"key":"10.1002\/humu.22124-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/jm201633y","article-title":"Rapid assembly of a library of lipophilic iminosugars via the thiol-ene reaction yields promising pharmacological chaperones for the treatment of Gaucher disease","volume":"55","author":"Goddard-Borger","year":"2012","journal-title":"J Med Chem"},{"key":"10.1002\/humu.22124-BIB36|cit36","doi-asserted-by":"crossref","first-page":"e29861","DOI":"10.1371\/journal.pone.0029861","article-title":"High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase","volume":"7","author":"Goldin","year":"2012","journal-title":"PLoS One"},{"key":"10.1002\/humu.22124-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/humu.22124-BIB38|cit38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bcmd.2010.08.012","article-title":"Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity","volume":"46","author":"Gupta","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1002\/humu.22124-BIB39|cit39","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1073\/pnas.94.12.6210","article-title":"Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells","volume":"94","author":"Halaban","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.22124-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1146\/annurev.biochem.73.011303.073752","article-title":"Roles of N-linked glycans in the endoplasmic reticulum","volume":"73","author":"Helenius","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1002\/humu.22124-BIB41|cit41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1002\/humu.22124-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI117160","article-title":"Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease","volume":"93","author":"Holleran","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1002\/humu.22124-BIB43|cit43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jb\/mvp194","article-title":"Mechanism and components of endoplasmic reticulum-associated degradation","volume":"147","author":"Hoseki","year":"2010","journal-title":"J Biochem"},{"key":"10.1002\/humu.22124-BIB44|cit44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.22124-BIB45|cit45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ncb746","article-title":"Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48","volume":"4","author":"Jarosch","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1002\/humu.22124-BIB46|cit46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0092-8674(95)90241-4","article-title":"Multiple proteolytic systems, including the proteasome, contribute to CFTR processing","volume":"83","author":"Jensen","year":"1995","journal-title":"Cell"},{"key":"10.1002\/humu.22124-BIB47|cit47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/jhg.2011.37","article-title":"Identification of a novel recombinant mutation in Korean patients with Gaucher disease using a long-range PCR approach","volume":"56","author":"Jeong","year":"2011","journal-title":"J Hum Genet"},{"key":"10.1002\/humu.22124-BIB48|cit48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1463-1326.2010.01281.x","article-title":"The unfolded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in beta-cells","volume":"12","author":"Kaufman","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1002\/humu.22124-BIB49|cit49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bcmd.2008.05.002","article-title":"Identification of Gaucher disease mutations found in Saudi Arabia","volume":"41","author":"Kaya","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1002\/humu.22124-BIB50|cit50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1002\/humu.22124-BIB51|cit51","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"Korkotian","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.22124-BIB52|cit52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/34438","article-title":"COPII-cargo interactions direct protein sorting into ER-derived transport vesicles","volume":"391","author":"Kuehn","year":"1998","journal-title":"Nature"},{"key":"10.1002\/humu.22124-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/archinte.167.11.1189","article-title":"Risk of malignant disease among 1525 adult male US veterans with Gaucher disease","volume":"167","author":"Landgren","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1002\/humu.22124-BIB54|cit54","first-page":"79","article-title":"Complex alleles of the acid beta-glucosidase gene in Gaucher disease","volume":"47","author":"Latham","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.22124-BIB55|cit55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bcmd.2011.02.002","article-title":"Identification of a novel mutation, I403T, in Cuban type 1 Gaucher disease","volume":"46","author":"Lavaut","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1002\/humu.22124-BIB56|cit56","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1083\/jcb.201001039","article-title":"Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy","volume":"189","author":"Lee","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.22124-BIB57|cit57","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature02592","article-title":"A membrane protein required for dislocation of misfolded proteins from the ER","volume":"429","author":"Lilley","year":"2004","journal-title":"Nature"},{"key":"10.1002\/humu.22124-BIB58|cit58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","article-title":"N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/humu.22124-BIB59|cit59","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.22124-BIB60|cit60","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.21684","article-title":"Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types-correlation with genotype and phenotype","volume":"85","author":"Lo","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1002\/humu.22124-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"Lucking","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.22124-BIB62|cit62","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/adc.63.7.854","article-title":"Collodion babies with Gaucher's disease","volume":"63","author":"Lui","year":"1988","journal-title":"Arch Dis Child"},{"key":"10.1002\/humu.22124-BIB63|cit63","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.22124-BIB64|cit64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(89)90115-2","article-title":"Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases","volume":"180","author":"Maley","year":"1989","journal-title":"Anal Biochem"},{"key":"10.1002\/humu.22124-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/jm1008902","article-title":"Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity","volume":"54","author":"Marugan","year":"2012","journal-title":"J Med Chem"},{"key":"10.1002\/humu.22124-BIB66|cit66","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)80767-9","article-title":"BiP acts as a molecular ratchet during posttranslational transport of prepro-alpha factor across the ER membrane","volume":"97","author":"Matlack","year":"1999","journal-title":"Cell"},{"key":"10.1002\/humu.22124-BIB67|cit67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1002\/humu.22124-BIB68|cit68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1083\/jcb.132.3.291","article-title":"Assembly of ER-associated protein degradation in vitro: dependence on cytosol, calnexin, and ATP","volume":"132","author":"McCracken","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.22124-BIB69|cit69","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1098\/rstb.2008.2273","article-title":"Progress in the pathogenesis and genetics of Parkinson's disease","volume":"363","author":"Mizuno","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1002\/humu.22124-BIB70|cit70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu Rev Neurosci"},{"key":"10.1002\/humu.22124-BIB71|cit71","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00216-011-5496-z","article-title":"A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide","volume":"402","author":"Motabar","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1002\/humu.22124-BIB72|cit72","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"Mu","year":"2008","journal-title":"Cell"},{"key":"10.1002\/humu.22124-BIB73|cit73","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/oxfordjournals.jbchem.a122629","article-title":"Structure of full-length cDNA coding for sulfatide activator, a Co-beta-glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator","volume":"105","author":"Nakano","year":"1989","journal-title":"J Biochem"},{"key":"10.1002\/humu.22124-BIB74|cit74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1083\/jcb.200809125","article-title":"Parkin is recruited selectively to impaired mitochondria and promotes their autophagy","volume":"183","author":"Narendra","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.22124-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.2842863","article-title":"Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus","volume":"241","author":"O'Brien","year":"1988","journal-title":"Science"},{"key":"10.1002\/humu.22124-BIB76|cit76","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nchembio.368","article-title":"Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis","volume":"6","author":"Ong","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1002\/humu.22124-BIB77|cit77","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004010050960","article-title":"Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant","volume":"97","author":"Pampols","year":"1999","journal-title":"Acta Neuropathol"},{"key":"10.1002\/humu.22124-BIB78|cit78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/bj3170081","article-title":"Overexpression of human glucocerebrosidase containing different-sized leaders","volume":"317","author":"Pasmanik-Chor","year":"1996","journal-title":"Biochem J"},{"key":"10.1002\/humu.22124-BIB79|cit79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2004.09.004","article-title":"Enhanced calcium release in the acute neuronopathic form of Gaucher disease","volume":"18","author":"Pelled","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1002\/humu.22124-BIB80|cit80","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cbpa.2004.09.009","article-title":"Polyubiquitin chains: polymeric protein signals","volume":"8","author":"Pickart","year":"2004","journal-title":"Curr Opin Chem Biol"},{"key":"10.1002\/humu.22124-BIB81|cit81","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1093\/emboj\/16.15.4540","article-title":"Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation","volume":"16","author":"Pilon","year":"1997","journal-title":"Embo J"},{"key":"10.1002\/humu.22124-BIB82|cit82","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.22124-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01233949","article-title":"Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency","volume":"19","author":"Rafi","year":"1993","journal-title":"Somat Cell Mol Genet"},{"key":"10.1002\/humu.22124-BIB84|cit84","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"10.1002\/humu.22124-BIB85|cit85","first-page":"225","article-title":"Human sphingolipid activator protein-1 and sphingolipid activator protein-2 are encoded by the same gene","volume":"1","author":"Reiner","year":"1989","journal-title":"J Mol Neurosci"},{"key":"10.1002\/humu.22124-BIB86|cit86","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0378-1119(88)90511-2","article-title":"Differential expression of the human glucocerebrosidase-coding gene","volume":"73","author":"Reiner","year":"1988","journal-title":"Gene"},{"issue":"2","key":"10.1002\/humu.22124-BIB87|cit87","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/dna.1988.7.107","article-title":"Structural analysis of the human glucocerebrosidase genes","volume":"7","author":"Reiner","year":"1988","journal-title":"DNA"},{"key":"10.1002\/humu.22124-BIB88|cit88","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.22124-BIB89|cit89","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ymgme.2007.10.132","article-title":"Intracellular cholesterol modifies the ERAD of glucocerebrosidase in Gaucher disease patients","volume":"93","author":"Ron","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1002\/humu.22124-BIB90|cit90","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","article-title":"Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease","volume":"19","author":"Ron","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.22124-BIB91|cit91","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0888-7543(89)90014-1","article-title":"Molecular cloning of a human co-beta-glucosidase cDNA: evidence that four sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats","volume":"5","author":"Rorman","year":"1989","journal-title":"Genomics"},{"key":"10.1002\/humu.22124-BIB92|cit92","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: a study from the Gaucher registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"key":"10.1002\/humu.22124-BIB93|cit93","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1002\/humu.20776","article-title":"Haplotype analysis suggests a single Balkan origin for the Gaucher disease [D409H;H255Q] double mutant allele","volume":"29","author":"Santamaria","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.22124-BIB94|cit94","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.22124-BIB95|cit95","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.22124-BIB96|cit96","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.biocel.2005.05.008","article-title":"Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease","volume":"37","author":"Schmitz","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1002\/humu.22124-BIB97|cit97","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(91)80760-Z","article-title":"Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease","volume":"284","author":"Schnabel","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1002\/humu.22124-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1083\/jcb.200804053","article-title":"Role of Sec61p in the ER-associated degradation of short-lived transmembrane proteins","volume":"181","author":"Scott","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.22124-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.bbrc.2006.08.173","article-title":"Ubiquitin ligase gp78 increases solubility and facilitates degradation of the Z variant of alpha-1-antitrypsin","volume":"349","author":"Shen","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/humu.22124-BIB100|cit100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1097-0142(19930701)72:1<219::AID-CNCR2820720139>3.0.CO;2-Y","article-title":"Increased risk of cancer in patients with Gaucher disease","volume":"72","author":"Shiran","year":"1993","journal-title":"Cancer"},{"key":"10.1002\/humu.22124-BIB101|cit101","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1203\/00006450-199210000-00023","article-title":"Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene","volume":"32","author":"Sidransky","year":"1992","journal-title":"Pediatr Res"},{"key":"10.1002\/humu.22124-BIB102|cit102","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1203\/00006450-199601000-00020","article-title":"Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease","volume":"39","author":"Sidransky","year":"1996","journal-title":"Pediatr Res"},{"key":"10.1002\/humu.22124-BIB103|cit103","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.22124-BIB104|cit104","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1471-4159.2005.03428.x","article-title":"CHOP\/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism","volume":"95","author":"Silva","year":"2005","journal-title":"J Neurochem"},{"key":"10.1002\/humu.22124-BIB105|cit105","first-page":"1016","article-title":"The human glucocerebrosidase gene has two functional ATG initiator codons","volume":"41","author":"Sorge","year":"1987","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.22124-BIB106|cit106","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.22124-BIB107|cit107","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.22124-BIB108|cit108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patients with type 3 Gaucher disease","volume":"97","author":"Tajima","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1002\/humu.22124-BIB109|cit109","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1083\/jcb.201007013","article-title":"Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin","volume":"191","author":"Tanaka","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.22124-BIB110|cit110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and Parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol Genet Metab"},{"key":"10.1002\/humu.22124-BIB111|cit111","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1203\/00006450-199805000-00003","article-title":"Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease","volume":"43","author":"Tayebi","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1002\/humu.22124-BIB112|cit112","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/mgme.1999.2918","article-title":"Type 2 Gaucher disease: an expanding phenotype","volume":"68","author":"Tayebi","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1002\/humu.22124-BIB113|cit113","first-page":"212","article-title":"Gaucher disease: molecular heterogeneity and phenotype-genotype correlations","volume":"45","author":"Theophilus","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.22124-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0021-9258(18)52343-7","article-title":"Identification of distinct endoglycosidase (endo) activities in Flavobacterium meningosepticum: endo F1, endo F2, and endo F3. Endo F1 and endo H hydrolyze only high mannose and hybrid glycans","volume":"266","author":"Trimble","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.22124-BIB115|cit115","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM198703053161002","article-title":"A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease","volume":"316","author":"Tsuji","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.22124-BIB116|cit116","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.85.7.2349","article-title":"Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals","volume":"85","author":"Tsuji","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.22124-BIB117|cit117","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","article-title":"Non-neuronopathic Gaucher disease due to saposin C deficiency","volume":"72","author":"Tylki-Szymanska","year":"2007","journal-title":"Clin Genet"},{"key":"10.1002\/humu.22124-BIB118|cit118","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/humu.21566","article-title":"A mutation in SCARB2 is a modifier in Gaucher disease","volume":"32","author":"Velayati","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.22124-BIB119|cit119","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nrm2546","article-title":"One step at a time: endoplasmic reticulum-associated degradation","volume":"9","author":"Vembar","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1002\/humu.22124-BIB120|cit120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/cb100321m","article-title":"Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts","volume":"6","author":"Wang","year":"2011","journal-title":"ACS Chem Biol"},{"key":"10.1002\/humu.22124-BIB121|cit121","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/hmg\/ddm324","article-title":"ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones","volume":"17","author":"Wei","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.22124-BIB122|cit122","doi-asserted-by":"crossref","first-page":"33883","DOI":"10.1074\/jbc.M803054200","article-title":"Sec61p is required for ERAD-L: genetic dissection of the translocation and ERAD-L functions of Sec61P using novel derivatives of CPY","volume":"283","author":"Willer","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.22124-BIB123|cit123","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1002\/humu.22124-BIB124|cit124","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1002\/humu.22124-BIB125|cit125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02656","article-title":"A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol","volume":"429","author":"Ye","year":"2004","journal-title":"Nature"},{"key":"10.1002\/humu.22124-BIB126|cit126","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1073\/pnas.0705637104","article-title":"Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease","volume":"104","author":"Zheng","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.22124-BIB127|cit127","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","article-title":"Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)","volume":"188","author":"Zimmer","year":"1999","journal-title":"J Pathol"},{"key":"10.1002\/humu.22124-BIB128|cit128","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood-2011-04-308890","article-title":"How I treat Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.22124","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/humu.22124\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T19:20:14Z","timestamp":1713986414000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.22124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,11]]},"references-count":128,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.22124","relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,11]]}}}